Overview

Ondansetron for the Treatment of Cocaine Dependence - 1

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
University of Texas
Treatments:
Cocaine
Ondansetron
Criteria
Inclusion Criteria:

Male/Female, at least 18 yrs of age; DSM-4 diagnosis of cocaine dependence; seeking
Treatment for cocaine dependence; have ability to understand, having understood and provide
written consent; females of child bearing potential that use accepted method of birth
control

Exclusion Criteria:

Additional criteria available during screening at the site.